Management of chronic noncancer pain in the primary care setting

Southern Medical Journal

Volumn 100, Issue 10, 2007, Pages 1028-1036

  Nicholson, Bruce ^a   Passik, Steven D ^a  

^a NONE

Author keywords

Chronic noncancer pain; Controlled release opioids; Pain management

Indexed keywords

IBUPROFEN; OPIATE; PARACETAMOL;

ANALGESIA; BEHAVIOR CHANGE; CHRONIC NONCANCER PAIN; CHRONIC PAIN; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED RELEASE FORMULATION; DAILY LIFE ACTIVITY; DRUG DEPENDENCE; DRUG MONITORING; GASTROINTESTINAL TOXICITY; HEALTH CARE PERSONNEL; HUMAN; LIVER TOXICITY; LONG TERM CARE; MEDICAL ASSESSMENT; PRESCRIPTION; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY DISTRESS; REVIEW; RISK FACTOR; RISK MANAGEMENT; SCREENING; SLEEP; SOMNOLENCE; VOMITING;

CHRONIC DISEASE; DELAYED-ACTION PREPARATIONS; DRUG MONITORING; HUMANS; NARCOTICS; OPIOID-RELATED DISORDERS; PAIN; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; QUALITY OF LIFE; SLEEP;

EID: 35148850160     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3180f626ff     Document Type: Review

References (43)

1. Carrington Reid M, Engles-Horton LL, Weber MB, et al. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002;17:173-179.
2. Nicholson B, Ross E, Weil A, et al. Treatment of chronic moderate-tosevere non-malignant pain with polymer-coated extended-release morphine sulfate capsules. Curr Med Res Opin 2006;22:539-550.
3. Longo LP, Parran T Jr, Johnson B, et al. Addiction, part II: identification and management of the drug-seeking patients. Am Fam Physician 2000;61:2401-2409.
4. Manchikanti L, Manchukonda R, Damron KS, et al. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician 2006;9:57-60.
5. Olsen Y, Daumit GL. Chronic pain and narcotics: a dilemma for primary care. J Gen Intern Med 2002;17:238-240.
6. Passik SD, Weinreb HJ. Managing chonic nonmalignant pain: overcoming obstacles to the use of opioids. Adv Ther 2000;17:70-80.
7. Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003;63:17-32.
8. Passik SD, Kirsh KL, Whitcomb L, et al. Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the Pain Assessment and Documentation Tool. J Opioid Manage 2005;1:257-266.
9. Kalso E, Edwards JE, Moore RA, et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372-380.
10. Markenson JA, Croft J, Zhang PG, et al. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 2005;21:524-535.
11. Ballantyne JC, Mao J. Medical progress: opioid therapy for chronic pain. N Engl J Med 2003;349:1943-1953.
12. Matsumoto AK, Babul N, Ahdieh H. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial. Pain Med 2006;6:357-366.
13. Eisenberg E, McNichol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin. JAMA 2005;293:3043-3052.
14. Palangio M, Damask MJ, Morris E, et al. Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain. Clin Ther 2000;22:879-892.
15. Kivitz A, Ma C, Ahdieh H, et al. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 2006;28:352-364.
16. McIlwain H, Ahdieh H. Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year study. Am J Ther 2005;12:106-112.
17. Gilderman L. Twice-daily dosing of controlled-release hydrocodone and acetaminophen tablets provides significant relief of moderate to severe osteoarthritis pain. Presented at: American Osteopathic Association; October 16, 2006 in Las Vegas, NV.
18. Hale ME, Dvergsten C, Gimbel J. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. J Pain 2005;6:21-28.
19. Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manage 2003;26:1026-1048.
20. Miaskowski C, Dodd MJ, West C, et al. Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol 2001;19:4275-4279.
21. Carr DB, Goudas LC, Balk EM, et al. Evidence report on the treatment of pain in cancer patients. J Natl Cancer Inst Monographs 2004;32:23-31.
22. Manchikanti L, Cash KA, Damron KS, et al. Controlled substance abuse and illicit drug use in chronic pain patients: an evaluation of multiple variables. Pain Physician 2006;9:215-226.
23. Holmes CP, Gatchel RJ, Adams LL, et al. An opioid screening instrument: Long-term evaluation of the utility of the Pain Medication Questionnaire. Pain Pract 2006;6:74-88.
24. Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 2006;6:46.
25. Butler SF, Budman SH, Fernandez K, et al. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004;112:65-75.
26. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 2005;6:432-442.
27. Dhingra LK, Passik SD. Rapid-onset opioids: recognizing and preventing abuse, addiction, and diversion. Available at: http://www.medscape.com/ viewarticle/533051. Accessed October 21, 2006 .
28. Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain 2002;18(4 Suppl):S28-S38.
29. Weaver M, Schnoll S. Abuse liability in opioid therapy for pain treatment in patients with an addiction history. Clin J Pain 2002;18(4 Suppl):S61-S69.
30. Fine PG, Portenoy RK. A Clinical Guide to Opioid Analgesia. Minneapolis, McGraw-Hill Companies, Inc, 2004.
31. Substance Abuse and Mental Health Services Administration. Overview of Findings from the 2003 National Survey on Drug Use and Health (Office of Applied Studies, NSDUH Series H-24, DHHS Publication No. SMA 04-3963). Rockville, MD.
32. Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain 1992;8:77-85.
33. Breivik H. Opioids in chronic non-cancer pain, indications and controversies. Eur J Pain 2005;9:127-130.
34. Definitions related to the treatment of opioids for the treatment of pain: A consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. 2001. Available at: http://www.ampainsoc.org/advocacy. Accessed September 10, 2006.
35. Federation of State Medical Boards of the United States I. Model policy for the use of controlled substances for the treatment of pain. Available at: http://www.fsmb.org/grpol_policydocs.html. Accessed October 21, 2006.
36. McCarberg BH, Barkin RL. Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther 2001;8:181-186.
37. Weissman DE, Haddox JD. Opioid pseudoaddiction-an iatrogenic syndrome. Pain 1989;36:363-366.
38. Practice guidelines for chronic pain management: a report by the American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section. Anesthesiology 1997;86:995-1004.
39. The use of opioids for the treatment of chronic pain: A consensus statement from American Academy of Pain Medicine and American Pain Society, 1996. Available at: http://www.ampainsoc.org/advocacy. Accessed September 10, 2006.
40. Public policy statement on the rights and responsibilities of healthcare professionals in the use of opioids for the treatment of pain, 2004. Available at: http://www.ampainsoc.org/advocacy. Accessed September 10, 2006.
41. Portenoy RK, Sciberras A, Eliot L, et al. Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain. J Pain Symptom Manage 2002;23:292-300.
42. Gallagher R. Opioids in chronic pain management: Navigating the clinical and regulatory challenges. J Fam Pract 2004;53:S23-S32.
43. Screener and Opioid Assessment for Patients with Pain (SOAPP®) Version 1.0-SF. Available at: http://www.painEDU.org. Accessed October 30, 2006.